TW202146013A - 含l-麥角硫鹼的組成物 - Google Patents

含l-麥角硫鹼的組成物 Download PDF

Info

Publication number
TW202146013A
TW202146013A TW110107636A TW110107636A TW202146013A TW 202146013 A TW202146013 A TW 202146013A TW 110107636 A TW110107636 A TW 110107636A TW 110107636 A TW110107636 A TW 110107636A TW 202146013 A TW202146013 A TW 202146013A
Authority
TW
Taiwan
Prior art keywords
egt
dth
composition
mass
dimethyl
Prior art date
Application number
TW110107636A
Other languages
English (en)
Chinese (zh)
Inventor
仲谷豪
仲島菜菜実
Original Assignee
日商長瀨產業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商長瀨產業股份有限公司 filed Critical 日商長瀨產業股份有限公司
Publication of TW202146013A publication Critical patent/TW202146013A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
TW110107636A 2020-03-04 2021-03-04 含l-麥角硫鹼的組成物 TW202146013A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-036577 2020-03-04
JP2020036577A JP6864131B1 (ja) 2020-03-04 2020-03-04 Ｌ−エルゴチオネイン含有組成物

Publications (1)

Publication Number Publication Date
TW202146013A true TW202146013A (zh) 2021-12-16

Family

ID=75638746

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110107636A TW202146013A (zh) 2020-03-04 2021-03-04 含l-麥角硫鹼的組成物

Country Status (8)

Country Link
US (1) US12357614B2 (https=)
EP (1) EP4115881A4 (https=)
JP (3) JP6864131B1 (https=)
KR (1) KR20220149718A (https=)
CN (1) CN115209895A (https=)
CA (1) CA3170408A1 (https=)
TW (1) TW202146013A (https=)
WO (1) WO2021177397A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118215476A (zh) * 2021-11-08 2024-06-18 三菱瓦斯化学株式会社 用于抑制或预防内耳性耳聋的含有麦角硫因的组合物
KR20240127428A (ko) * 2021-12-23 2024-08-22 산토리 홀딩스 가부시키가이샤 경구 조성물 및 소프트 캡슐제
CN121311472A (zh) * 2023-06-15 2026-01-09 长濑产业株式会社 化合物或其盐及其制造方法、组合物、过氧化氢清除剂以及细胞毒性抑制剂
WO2025142813A1 (ja) * 2023-12-27 2025-07-03 サントリーホールディングス株式会社 経口組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707086A1 (fr) * 1993-06-28 1995-01-06 Bioxytech Procédé de préparation de l'ergothionéine.
DE102004020714A1 (de) * 2004-04-26 2005-11-10 Beiersdorf Ag Haut- und/oder Haarmittel enthaltend Verbindungen mit isoprenoider Struktur
FR2910808B1 (fr) * 2006-12-29 2009-04-10 Lvmh Rech Utilisation en cosmetique de la l-2-thiohistidine ou d'un de ses derives comme agent depigmentant.
US7767826B2 (en) 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
JP2009126863A (ja) * 2007-11-27 2009-06-11 Koei Kogyo Kk キノコから抽出したエルゴチオネインを高含有する組成物
FR2950889B1 (fr) * 2009-10-06 2011-11-18 Tetrahedron Procede de synthese de l'ergothioneine et analogues
FR2950890B1 (fr) * 2009-10-06 2011-12-30 Tetrahedron Procede de synthese de la 2-thiohistidine et analogues
AU2013234815B2 (en) 2012-03-23 2017-06-22 The University Of Queensland Immunomodulatory agent and uses therefor
GB201416678D0 (en) * 2014-09-22 2014-11-05 Univ Cape Town Process For Synthesizing Ergothioneine And Its Intermediates
EP3252142B1 (en) * 2015-01-30 2021-11-03 Kikkoman Corporation Transformed fungus having enhanced ergothioneine productivity and method for producing ergothioneine
WO2019089878A1 (en) 2017-11-02 2019-05-09 Colorado Seminary, Owner and Operator of University of Denver Methods of treating microbial infection and inflammation
US11098330B2 (en) 2018-02-23 2021-08-24 Nagase & Co., Ltd. Method for producing ergothioneine
JP7185213B2 (ja) * 2018-03-02 2022-12-07 国立大学法人 筑波大学 エルゴチオネイン合成微生物、及びエルゴチオネインの製造方法

Also Published As

Publication number Publication date
JPWO2021177397A1 (https=) 2021-09-10
CA3170408A1 (en) 2021-09-10
CN115209895A (zh) 2022-10-18
JP6864131B1 (ja) 2021-04-28
JP2021138640A (ja) 2021-09-16
EP4115881A4 (en) 2024-04-03
EP4115881A1 (en) 2023-01-11
BR112022017415A2 (pt) 2022-10-18
JP2026021447A (ja) 2026-02-10
WO2021177397A1 (ja) 2021-09-10
KR20220149718A (ko) 2022-11-08
US12357614B2 (en) 2025-07-15
US20230126387A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
TW202146013A (zh) 含l-麥角硫鹼的組成物
JP5479891B2 (ja) 新規ローヤルゼリー分画物とその製造方法並びに用途
JP2008179632A (ja) 抗酸化剤
JP2011063563A (ja) しわ改善組成物
KR102139659B1 (ko) 피부 개선용 조성물
JP4828922B2 (ja) 抗アレルギー剤
KR101046688B1 (ko) 아스퍼질러스 테리우스 추출물, 신규 부티로락톤 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 항산화용 조성물
TWI308152B (https=)
JP7240565B2 (ja) Ｌ－エルゴチオネイン含有組成物
JP2006089385A (ja) 美肌用組成物
JP7727671B2 (ja) ホモシステイン誘導体及びその製造方法、組成物、並びに、炎症抑制剤
HK40075066A (en) L-ergothioneine-containing composition
BR112022017415B1 (pt) Composição contendo l-ergotioneína
BR122023019667B1 (pt) Método de produção de uma composição contendo l-ergotioneína e n, n-dimetil-l-2-tiohistidina e método de supressão de coloração da composição
TWI918846B (zh) 升半胱胺酸衍生物及其製造方法、組成物、以及發炎抑制劑
JP2006083115A (ja) 美肌用組成物
JP7771432B2 (ja) 睡眠改善剤
JP7457353B2 (ja) 軟骨細胞への分化促進剤、軟骨細胞の増殖促進剤および軟骨基質産生促進剤
JP2006008597A (ja) 美肌用のキット
JP6928337B2 (ja) Ｎｏ産生抑制剤
JP2006083113A (ja) 美肌用組成物
KR20240081842A (ko) 유색미 추출물을 유효성분으로 포함하는 피부 주름의 예방, 개선 또는 치료용 조성물
JP2017088553A (ja) 抗糖化剤
JP2018135328A (ja) ＴＮＦα産生抑制剤